Skip to main content
. 2020 Apr 24;11:511. doi: 10.3389/fphar.2020.00511

Figure 8.

Figure 8

Kim-1 and CLU immunoreactivity in the kidneys of SD rats treated with a single intravenous dose of 15mg/kg/day BW for 5 days. In Kim-1 immunoreactivity was shown in, (A) vehicle, (B) AmB and (C) SM21. Only occasional Kim-1-positive tubules were detected in SM21 (blue arrow in C) kidneys. Kim-1 was prominently detected translocated to an apical (luminal) membrane of convoluted portion of the proximal tubules in AmB group. In CLU immunoreactivity was shown in, (D) Vehicle (E) AmB, (F) SM21. In AmB group, high expression of CLU observed over almost all different tubules. Positive pixel analysis identified a low increase in immunoreactivity in rats dosed with SM21 group compared to control. However, this expression is comparatively lower than AmB treatment. No immunoreactivity of Kim-1 and CLU were detected in vehicle group. IHC profiler was used to assign an automated score to the respective IHC images by computerized pixel profiling based on colour deconvolution acquired on Image J. Kim-1, Kidney injury molecule-1; CLU, Clusterin; SD, Sprague Dawley; IHC, Immunohistochemistry.